loading...| Preferred Name |
oritavancin |
|
| Synonyms |
(4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(3'')-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin Chlorobiphenyl-chloroeremomycin LY333328 |
|
| Definitions |
A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_82699 |
|
| charge |
0 |
|
| chemical inhibits in vitro invasion of virus | ||
| database_cross_reference |
PMID:25239268 PMID:25294250 PMID:23261897 PMID:24550323 PMID:25058176 KEGG:C12034 Wikipedia:Oritavancin Drug_Central:4678 Reaxys:7608605 CAS:171099-57-3 PMID:23759507 PMID:25118105 PMID:24035967 PMID:23089749 PMID:24449768 PMID:22941898 PMID:24897083 PMID:24906505 PMID:25294303 PMID:25022588 PMID:24505091 |
|
| definition source |
PMID: 26953343; PMID: 28855003; PMID: 16081529 |
|
| formula |
C86H97Cl3N10O26 |
|
| has functional parent | ||
| has role | ||
| has_alternative_id |
CHEBI:29553 |
|
| has_obo_namespace |
chebi_ontology |
|
| has_related_synonym |
(4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(3'')-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin Chlorobiphenyl-chloroeremomycin LY333328 |
|
| id |
CHEBI:82699 |
|
| imported from | ||
| in subset | ||
| inchi |
InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1 |
|
| inchikey |
VHFGEBVPHAGQPI-LXKZPTCJSA-N |
|
| label |
oritavancin |
|
| mass |
1793.10100 |
|
| monoisotopicmass |
1790.56411 |
|
| notation |
CHEBI:82699 |
|
| prefLabel |
oritavancin |
|
| smiles |
CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O[C@H]5C[C@](C)(N)[C@@H](O)[C@H](C)O5)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(NCc3ccc(cc3)-c3ccc(Cl)cc3)[C@@H](O)[C@H](C)O1)c(Cl)c2 |
|
| textual definition |
A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA. |
|
| subClassOf |
http://purl.obolibrary.org/obo/CHEBI_72588 |
This ontology integrates with OntoloBridge, allowing community users to suggest additions to the public ontology. Complete the template below to submit a term request directly to the ontology maintainer.
Term Label (required)
Suggested term name. If a term can be described with multiple synonyms, only list the preferred name here.
Term description (required)
A brief definition, description, or usage of your suggested term. Additional term synonyms may be listed in this section.
Superclass (required)
The parent term of the suggested term. The parent term should be an existing entry of the current ontology. The superclass can be selected directly from Bioportal's Classes tree viewer.
References (optional)
Provide evidence for the existence of the requested term such as Pubmed IDs of papers or links to other resources that describe the term.
Justification (optional)
Provide any additional information about the requested term here.